Eagle Pharmaceuticals Inc. (EGRX) Declined -5.37% or -2.99 To Price $52.69 On Thursday


Eagle Pharmaceuticals Inc. (EGRX) declined -5.37% or -2.99 to $52.69. It is about 297394 shares traded, which is 102.97% compare to the average total volume 288803. The market cap of EGRX is $783.08 million. The year to date change is -4.35%. The 52 week price range is from $45.05 to $97.15. Price of EGRX have changed -4.46% during last week. It have changed -6.25% over last month, -3.20% over last 3 months, -7.75% over last 6 months and -30.45% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for EGRX is 59.27. It is 12.49% above current price. The 200-day Moving Averages for EGRX is 60.63. It is 15.07% above current price. The 52-week High is 97.15. It is 84.38% from the current price. The 52-week Low is 45.05. It is -14.50% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of EGRX is 10.63 on 2018-02-28. Short % to float is 24.86%. There are some statistics of EGRX. It is has market cap $783.08 million. The share outstanding is 14.86 million. The average volume is 288803. The revenue is 189.92M. It has 180.64M cash and 48.94M in debt. The gross profit is 146.44M. The percent of top 15 Institution holding is 97.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of EGRX is 31.45%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of EGRX is 21.45%.


Tags:

Share this post